Equillium (EQ) Net Equity Issued and Repurchased (2020 - 2025)
Equillium (EQ) posted quarterly Net Equity Issued and Repurchased of -$137000.0 for Q4 2025, down 298.55% year-over-year from $69000.0 in Q4 2024, and down 115.22% quarter-over-quarter from $900000.0 in Q3 2025.
Equillium (EQ) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Equillium (EQ) has reported Net Equity Issued and Repurchased for 4 consecutive years, with -$137000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased fell 298.55% year-over-year to -$137000.0; the TTM figure through Dec 2025 stood at $818000.0 (down 95.91% YoY), while the FY2025 annual figure was $682000.0, up 326.25% from the prior year.
- Net Equity Issued and Repurchased eased to -$137000.0 in Q4 2025 per EQ's latest filing, from $900000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $55.0 million in Q1 2025 and bottomed at -$54.9 million in Q2 2025.
- Historically, Net Equity Issued and Repurchased has averaged $4.4 million across 3 years, with a median of $900000.0 in 2025.
- Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased jumped 1190.32% — and 2025, when it sank 298.55%.
- Equillium's Net Equity Issued and Repurchased stood at $19.9 million in 2021, then plunged by 99.65% to $69000.0 in 2024, then tumbled by 298.55% to -$137000.0 in 2025.
- Business Quant data shows EQ's Net Equity Issued and Repurchased at -$137000.0 in Q4 2025, $900000.0 in Q3 2025, and -$54.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -137,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | -54.95 Mn |
| Jun 30, 2025 | -54.95 Mn |
| Mar 31, 2025 | 55.00 Mn |
| Mar 31, 2025 | 55.00 Mn |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2021 | 19.91 Mn |
| Dec 31, 2021 | 19.91 Mn |
| Mar 31, 2021 | 10.00 Mn |
| Mar 31, 2021 | 10.00 Mn |
| Dec 31, 2020 | -27.66 Mn |
| Dec 31, 2020 | -27.66 Mn |
| Sep 30, 2020 | 7.30 Mn |
| Sep 30, 2020 | 7.30 Mn |
| Jun 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 25,000.00 |